Buzz vans across the US over the next decade. The plan kicks off in Los Angeles, with testing starting later this year and commercial rides expected to launch in 2026. The ID. Buzz autonomous ...

Uber Technologies Inc. and Volkswagen AG have partnered to deploy thousands of electric ID Buzz vans in the US, marking the latest partnership to expand autonomous options on the ride hailing app.

Launching Vans’ Old Skool 36 FM sneaker, the Willo Perron-designed installation at Milan Design Week 2025 was inspired by the invisible architecture of sound ‘In their purest elemental form, what do ...

Mercedes-Benz has launched three new electric vans in Singapore, marking a huge step forward for the brand in helping its business partners move towards greater efficiency and electrification of ...

You file a patent application and you want to tell the U.S. Patent and Trademark Office (USPTO) how amazing your new technology is over anything that is out there previously. Here’s the problem ...

While Washington's endless drama dominates headlines, the Trump administration has been rewiring the foundations of American intellectual property (IP) policy. The administration's pro-patent ...

The Vision V previews what the German firm’s luxury vans of the future will look like. (Mercedes) Mercedes has revealed what its luxury vans of the future will look like with the Vision V Concept.

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters. Some states have laws and ethical rules regarding solicitation ...

China is experiencing rapid growth in its artificial intelligence (AI) sector and now holds 60 percent of the world's AI patents, the most globally, according to a World Intellectual Property ...

The US Senate has come together to pass a bill that aims to prevent pharma companies from filing multiple patents around biologic drugs as a way to delay biosimilar competitors. Lawmakers ...

A US jury has decided that Daiichi Sankyo and AstraZeneca's breast cancer drug Enhertu infringes a patent held by US biotech Seagen, awarding almost $42 million in damages. Seagen claims Enhertu ( ...